Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study Provides First Physiological Evidence that Insulin is Critical for Blood Vessel Formation

02.03.2006


Study One Day May Lead to Ways to Reduce Heart Attacks in Diabetes Patients

For people with type 2 diabetes, the death rate from a first heart attack is two to three times the death rate of patients without the disease. Similarly, patients with diabetes and ischemic (reduced blood flow) heart disease have a much higher mortality rate than the general population.

Now, a team of researchers at Joslin Diabetes Center led by George L. King, M.D., Director of Research and Head of Vascular Cell Biology, and Zhiheng He, M.D., Ph.D., a Juvenile Diabetes Research Foundation International Research Fellow and former Iacocca Fellow, has shown a potential physiological mechanism behind this difference. The discovery could one day lead to new treatments to improve the ability of patients with diabetes to survive heart attacks and live with coronary artery disease. The report was published in the Feb. 9 online edition of the American Heart Association journal, Arteriosclerosis, Thrombosis, and Vascular Biology, and is scheduled to appear in the April print edition.



Normally, when a coronary artery becomes blocked, the body responds by forming new blood vessels around the blockage to maintain blood and oxygen flow and limit heart damage. Heart cells produce the vessels by making VEGF, a growth factor that causes new blood vessel formation. “We have long recognized that in patients with diabetes, this blood vessel formation is not as robust as in people without diabetes,” says Dr. King, Professor of Medicine at Harvard Medical School. “Now we have a potential explanation.”

The researchers showed that insulin is the source of the signal the heart cells need to increase VEGF production. “We found that when insulin in the bloodstream binds with the insulin receptors on the outer membranes of heart cells, it activates the PI3K/AKT pathway, which is the pathway that produces VEGF,” says Dr. King. “We also found that this response is blunted in patients with insulin resistance, a major cause of type 2 diabetes that makes it harder for cells to use insulin. The heart produces less VEGF and forms fewer new blood vessels.”

The researchers made their findings by working with two types of rodents: Zucker rats, which are genetically obese and, like humans, develop type 2 diabetes through insulin resistance; and MIKRO (muscle-specific insulin receptor knockout) mice, a mouse model whose insulin receptor has been removed from the heart cells so they can no longer respond to the hormone.

“We found that when we stimulated the heart cells of Zucker rats with insulin and compared them with cells of normal rats, the insulin action in the Zucker rats was abnormal and that may be responsible for the reduced VEGF and blood vessel formation in the heart,” Dr. King explains. “Using a variety of interventional approaches, we then showed that the blood vessel formation was reduced because this one pathway was inhibited. The mice with the insulin receptor removed also exhibited less VEGF production and fewer new blood vessels, proving that the insulin receptor is critical to this process.

“The study suggests that if we improve VEGF and insulin action in the heart, then the heart will be able to produce more new blood vessels,” says Dr. King. “Scientists have already established several ways of improving insulin actions in general, so once we figure out which is best for the heart muscle, we should be able to decrease the mortality rate.”

Other researchers participating in the study include C. Ronald Kahn, M.D., Rohit N. Kulkarni, M.D., Ph.D., Darren Opland, Kohjiro Ueki, M.D., Ph.D., and Kerrie Way, Ph.D., of Joslin; Natalya Bodyak, Ph.D., Peter Kang, M.D., and Seigo Izumo, M.D., Ph.D., of Beth Israel Deaconess Medical Center, Boston; and Ronglih Liao, Ph.D., and Bo Wang, M.D., of Boston University School of Medicine.

Funding for the study was provided by the National Institute of Diabetes & Digestive & Kidney Diseases of the National Institutes of Health.

Marjorie Dwyer | EurekAlert!
Further information:
http://www.joslin.harvard.edu

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

When corals eat plastics

24.05.2018 | Ecology, The Environment and Conservation

Surgery involving ultrasound energy found to treat high blood pressure

24.05.2018 | Medical Engineering

First chip-scale broadband optical system that can sense molecules in the mid-IR

24.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>